Safety and Antitumor Activity of Pembrolizumab in Advanced Programmed Death Ligand 1-Positive Endometrial Cancer: Results from the KEYNOTE-028 Study

Patrick A. Ott; Yung Jue Bang; Dominique Berton-Rigaud; Elena Elez; Michael J. Pishvaian; Hope S. Rugo; Igor Puzanov; Janice M. Mehnert; Kyaw L. Aung; Juanita Lopez; Marion Carrigan; Sanatan Saraf; Mei Chen; Jean Charles Soria

doi:10.1097/01.ogx.0000527579.58363.20

Safety and Antitumor Activity of Pembrolizumab in Advanced Programmed Death Ligand 1-Positive Endometrial Cancer: Results from the KEYNOTE-028 Study

Patrick A. Ott, Yung Jue Bang, Dominique Berton-Rigaud, Elena Elez, Michael J. Pishvaian, Hope S. Rugo, Igor Puzanov, Janice M. Mehnert, Kyaw L. Aung, Juanita Lopez, Marion Carrigan, Sanatan Saraf, Mei Chen, Jean Charles Soria

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	26-27
Number of pages	2
Journal	Obstetrical and Gynecological Survey
Volume	73
Issue number	1
DOIs	https://doi.org/10.1097/01.ogx.0000527579.58363.20
State	Published - Jan 1 2018
Externally published	Yes

ASJC Scopus subject areas

Obstetrics and Gynecology

Access to Document

10.1097/01.ogx.0000527579.58363.20

Cite this

Ott, P. A., Bang, Y. J., Berton-Rigaud, D., Elez, E., Pishvaian, M. J., Rugo, H. S., Puzanov, I., Mehnert, J. M., Aung, K. L., Lopez, J., Carrigan, M., Saraf, S., Chen, M., & Soria, J. C. (2018). Safety and Antitumor Activity of Pembrolizumab in Advanced Programmed Death Ligand 1-Positive Endometrial Cancer: Results from the KEYNOTE-028 Study. Obstetrical and Gynecological Survey, 73(1), 26-27. https://doi.org/10.1097/01.ogx.0000527579.58363.20

Safety and Antitumor Activity of Pembrolizumab in Advanced Programmed Death Ligand 1-Positive Endometrial Cancer : Results from the KEYNOTE-028 Study. / Ott, Patrick A.; Bang, Yung Jue; Berton-Rigaud, Dominique; Elez, Elena; Pishvaian, Michael J.; Rugo, Hope S.; Puzanov, Igor; Mehnert, Janice M.; Aung, Kyaw L.; Lopez, Juanita; Carrigan, Marion; Saraf, Sanatan; Chen, Mei; Soria, Jean Charles.

In: Obstetrical and Gynecological Survey, Vol. 73, No. 1, 01.01.2018, p. 26-27.

Research output: Contribution to journal › Comment/debate › peer-review

Ott, PA, Bang, YJ, Berton-Rigaud, D, Elez, E, Pishvaian, MJ, Rugo, HS, Puzanov, I, Mehnert, JM, Aung, KL, Lopez, J, Carrigan, M, Saraf, S, Chen, M & Soria, JC 2018, 'Safety and Antitumor Activity of Pembrolizumab in Advanced Programmed Death Ligand 1-Positive Endometrial Cancer: Results from the KEYNOTE-028 Study', Obstetrical and Gynecological Survey, vol. 73, no. 1, pp. 26-27. https://doi.org/10.1097/01.ogx.0000527579.58363.20

Ott, Patrick A. ; Bang, Yung Jue ; Berton-Rigaud, Dominique ; Elez, Elena ; Pishvaian, Michael J. ; Rugo, Hope S. ; Puzanov, Igor ; Mehnert, Janice M. ; Aung, Kyaw L. ; Lopez, Juanita ; Carrigan, Marion ; Saraf, Sanatan ; Chen, Mei ; Soria, Jean Charles. / Safety and Antitumor Activity of Pembrolizumab in Advanced Programmed Death Ligand 1-Positive Endometrial Cancer : Results from the KEYNOTE-028 Study. In: Obstetrical and Gynecological Survey. 2018 ; Vol. 73, No. 1. pp. 26-27.

@article{934acb52db2e4f74be8ce46748c09540,

title = "Safety and Antitumor Activity of Pembrolizumab in Advanced Programmed Death Ligand 1-Positive Endometrial Cancer: Results from the KEYNOTE-028 Study",

author = "Ott, {Patrick A.} and Bang, {Yung Jue} and Dominique Berton-Rigaud and Elena Elez and Pishvaian, {Michael J.} and Rugo, {Hope S.} and Igor Puzanov and Mehnert, {Janice M.} and Aung, {Kyaw L.} and Juanita Lopez and Marion Carrigan and Sanatan Saraf and Mei Chen and Soria, {Jean Charles}",

year = "2018",

month = jan,

day = "1",

doi = "10.1097/01.ogx.0000527579.58363.20",

language = "English (US)",

volume = "73",

pages = "26--27",

journal = "Obstetrical and Gynecological Survey",

issn = "0029-7828",

publisher = "Lippincott Williams and Wilkins",

number = "1",

}

TY - JOUR

T1 - Safety and Antitumor Activity of Pembrolizumab in Advanced Programmed Death Ligand 1-Positive Endometrial Cancer

T2 - Results from the KEYNOTE-028 Study

AU - Ott, Patrick A.

AU - Bang, Yung Jue

AU - Berton-Rigaud, Dominique

AU - Elez, Elena

AU - Pishvaian, Michael J.

AU - Rugo, Hope S.

AU - Puzanov, Igor

AU - Mehnert, Janice M.

AU - Aung, Kyaw L.

AU - Lopez, Juanita

AU - Carrigan, Marion

AU - Saraf, Sanatan

AU - Chen, Mei

AU - Soria, Jean Charles

PY - 2018/1/1

Y1 - 2018/1/1

UR - http://www.scopus.com/inward/record.url?scp=85041111851&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041111851&partnerID=8YFLogxK

U2 - 10.1097/01.ogx.0000527579.58363.20

DO - 10.1097/01.ogx.0000527579.58363.20

M3 - Comment/debate

AN - SCOPUS:85041111851

VL - 73

SP - 26

EP - 27

JO - Obstetrical and Gynecological Survey

JF - Obstetrical and Gynecological Survey

SN - 0029-7828

IS - 1

ER -

Safety and Antitumor Activity of Pembrolizumab in Advanced Programmed Death Ligand 1-Positive Endometrial Cancer: Results from the KEYNOTE-028 Study

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this